Clinical, physiological, and histological features in a kindred with the T3271C melas mutation

Muscle and Nerve

Volumn 21, Issue 1, 1998, Pages 25-33

  Tarnopolsky, M A ^a,b   Maguire, J ^c   Myint, T ^d   Applegarth, D ^e   Robinson, B H ^d  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON GENERAL HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e BC CHILDREN S HOSPITAL   (Canada)

Author keywords

MELAS syndrome; Mitochondrial 3271 transfer RNA mutation; Mitochondrial myopathy

Indexed keywords

TRANSFER RNA;

ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; GENE MUTATION; HISTOLOGY; HUMAN; LACTIC ACIDOSIS; MITOCHONDRIAL MYOPATHY; NUCLEOTIDE SEQUENCE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; STROKE; SYNDROME;

ADENINE; ADULT; BIOPSY, NEEDLE; CHILD, PRESCHOOL; CYTOSINE; DNA; DNA, MITOCHONDRIAL; FEMALE; FOREARM; GUANINE; HUMANS; INFANT; ISCHEMIA; MALE; MELAS SYNDROME; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; NORTH AMERICA; PEDIGREE; POINT MUTATION; RNA; THYMINE;

EID: 0031982608     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I     Document Type: Article

References (14)

1. Arnold DL, Taylor DJ, Radda GK: Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
2. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, Simonetti S, Angelini C, Donati MA, Garcia C, Martinuzzi A, Mosewich R, Servidei S, Zammarchi E, Bonilla E, De Vivo DC, Rowland LP, Schon EA, DiMauro S: MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31:391-398.
3. Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, Bryan RN, Hurko O: Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathics demonstrates decreased levels of brain phosphocreatine. Ann Neurol 1990;27:626-630.
4. Goto Y: Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995;3:S107-S112.
5. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.
6. Goto Y, Nonaka I, Horai S: A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991;1097:238-240.
7. Goto Y, Horai S, Matsuoka T, et al.: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550.
8. Hasegawa H, Matsuoka T, Goto Y, Nonaka I: Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol 1991;29:601-605.
9. Leu(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. Biochem Biophys Res Commun 1993;197:1049-1055.
10. Koo B, Becker LE, Chuang S, Merante F, Robinson BH, MacGregor D, Tein I, HO VB, McGreal DA, Wherrett JR, Logan WJ: Mitochondrial encephalomyopathy, lactic acidosis, strokelike episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 1993;34:25-32.
11. Marie SKN, Goto Y, Passos-Bueno MR, Zatz M, Carvalho AAS, Carvalho M, Levy JA, Palou VB, Campiotto S, Horai S, Nonaka I: A Caucasian family with the 3271 mutation in mitochondrial DNA. Biochem Med Metab Biol 1994;52:136-139.
12. Mita S, Tokunaga M, Kumamoto T, Uchino M, Nonaka I, Ando M: Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Muscle Nerve 1995;18:S113-S118.
13. Sakuta R, Goto Y, Horai S, Nonaka I: Mitochondrial DNA mutations at nucleotide positions 3242 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a comparative study. J Neurol Sci 1993;115:158-160.
14. Tokunaga M, Mita S, Sakuta R, Nonaka I, Araki S: Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol 1993;33:275-280.